Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anal Canal Carcinoma × toripalimab × 1 year × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 12 Nasopharyngeal Carcinoma 11 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Esophageal Squamous Cell Carcinoma 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Colorectal Neoplasms 6 Carcinoma, Renal Cell 5 Advanced Solid Tumor 5 Uterine Cervical Neoplasms 4 Recurrence 4 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Solid Tumor 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 NSCLC 2 Esophageal Neoplasms 2 Carcinoma, Squamous Cell 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Stage IB-IIIB NSCLC 1 Solid Tumor, Adult 1 Solid Cancer 1

Interventions

Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiotherapy, Intensity-Modulated 2 Nivolumab 2 Fluorouracil 2 Biopsy 2 pembrolizumab 1 dehydroftorafur 1 X-Rays 1 Watchful Waiting 1 Sigmoidoscopy 1 Radiotherapy 1 Proctoscopy 1 Phantoms, Imaging 1 Observation 1 Mitozytrex 1 Mitomycin 1 Ipilimumab 1 Fluorodeoxyglucose F18 1 Colonoscopy 1 Cisplatin 1 Cetuximab 1 Capecitabine 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡